- Home
- KRON vs AIXI Comparison
KRON vs AIXI Comparison
Compare KRON & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRON
- AIXI
- Stock Information
- Founded
- KRON 2017
- AIXI 2001
- Country
- KRON United States
- AIXI China
- Employees
- KRON N/A
- AIXI N/A
- Industry
- KRON Medicinal Chemicals and Botanical Products
- AIXI Computer Software: Prepackaged Software
- Sector
- KRON Health Care
- AIXI Technology
- Exchange
- KRON Nasdaq
- AIXI Nasdaq
- Market Cap
- KRON 61.5M
- AIXI 54.2M
- IPO Year
- KRON 2020
- AIXI 2023
- Fundamental
- Price
- KRON $1.00
- AIXI $5.30
- Analyst Decision
- KRON Buy
- AIXI
- Analyst Count
- KRON 3
- AIXI 0
- Target Price
- KRON $1.63
- AIXI N/A
- AVG Volume (30 Days)
- KRON 226.0K
- AIXI 200.6K
- Earning Date
- KRON 03-20-2025
- AIXI 10-28-2024
- Dividend Yield
- KRON N/A
- AIXI N/A
- EPS Growth
- KRON N/A
- AIXI N/A
- EPS
- KRON N/A
- AIXI N/A
- Revenue
- KRON $9,864,000.00
- AIXI $65,643,604.00
- Revenue This Year
- KRON $62.21
- AIXI $22.85
- Revenue Next Year
- KRON N/A
- AIXI $22.70
- P/E Ratio
- KRON N/A
- AIXI N/A
- Revenue Growth
- KRON 146.48
- AIXI 6.22
- 52 Week Low
- KRON $0.69
- AIXI $2.06
- 52 Week High
- KRON $1.60
- AIXI $22.05
- Technical
- Relative Strength Index (RSI)
- KRON 50.71
- AIXI 53.73
- Support Level
- KRON $0.97
- AIXI $4.85
- Resistance Level
- KRON $1.03
- AIXI $5.43
- Average True Range (ATR)
- KRON 0.05
- AIXI 0.45
- MACD
- KRON 0.00
- AIXI 0.06
- Stochastic Oscillator
- KRON 65.52
- AIXI 83.71
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.